Evaluating the costs and benefits of pneumococcal vaccination in adults.

about

The full benefits of adult pneumococcal vaccination: A systematic review.

P2860

Q47098784-94C22273-3CC4-402E-8BB5-C7593FA7706B

P2860

Evaluating the costs and benefits of pneumococcal vaccination in adults.

Item

http://www.wikidata.org/entity/Q38966828

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evaluating the costs and benefits of pneumococcal vaccination in adults.

@en

type

Item

label

Evaluating the costs and benefits of pneumococcal vaccination in adults.

@en

prefLabel

Evaluating the costs and benefits of pneumococcal vaccination in adults.

@en

P1476

Evaluating the costs and benefits of pneumococcal vaccination in adults

@en

P2093

Angela Bechini

http://www.w3.org/2001/XMLSchema#string

Barbara Rita Porchia

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines for preventing pneumococcal infection in adults

A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly

Pneumococcal Vaccination Strategies. An Update and Perspective.

Adult immunization with 13-valent pneumococcal vaccine in Campania region, South Italy: an economic evaluation.

Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model.

Pneumococcal vaccination and revaccination of older adults.

Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia.

Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey.

Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil.

Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan

P304

93-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2017.1242419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Bonanni

Sara Boccalini

Guglielmo Bonaccorsi

P577

2016-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27680425

http://www.w3.org/2001/XMLSchema#string

Evaluating the costs and benefits of pneumococcal vaccination in adults.

about

P2860

P2860

Evaluating the costs and benefits of pneumococcal vaccination in adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698